Zofia E. Dziewanowska is VP & Clinical Research at LIGAND PHARMACEUTICALS INC (LGND). They have made 1 open-market trade across 1 company since 2009, most recently 2009-02-25.
CIK 0001392592
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LGND | 33,977 | $10.0M |
Shares reported on the most recent Form 4, priced at the 2009-02-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LGND | SELL | 2009-02-25 | 2009-02-27 | $2.62 | $16K | -9.9% | -3.4% | -3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.